Literature DB >> 9673834

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

A Hämmerlein1, H Derendorf, D T Lowenthal.   

Abstract

Age-related changes in pharmacokinetics principally affect drug absorption, distribution, metabolism and elimination. Changes in pharmacodynamics are primarily seen in the cardiovascular and neuroendocrine system. Age-dependent changes in the kinetics and dynamics of drugs acting on the cardiovascular system and central nervous system are common, and this review, while by no means exhaustive of the effects of drugs on all organ systems, is reflective of the principles and gives examples of the effects of age on these 2 major systems. While pharmacokinetic changes in the elderly are usually well characterised, pharmacodynamic changes are understood only in the most preliminary way. There has been relatively little research in this area of geriatric clinical pharmacology, and pharmacodynamic changes are still an area of investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673834     DOI: 10.2165/00003088-199835010-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  111 in total

1.  Effect on aging on plasma renin and aldosterone in normal man.

Authors:  P Weidmann; S De Myttenaere-Bursztein; M H Maxwell; J de Lima
Journal:  Kidney Int       Date:  1975-11       Impact factor: 10.612

2.  THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN.

Authors:  A D BENDER
Journal:  J Am Geriatr Soc       Date:  1965-03       Impact factor: 5.562

Review 3.  PHARMACOLOGIC ASPECTS OF AGING: A SURVEY OF THE EFFECT OF INCREASING AGE ON DRUG ACTIVITY IN ADULTS.

Authors:  A D BENDER
Journal:  J Am Geriatr Soc       Date:  1964-02       Impact factor: 5.562

Review 4.  Altered pharmacokinetics in the elderly.

Authors:  G J Yuen
Journal:  Clin Geriatr Med       Date:  1990-05       Impact factor: 3.076

Review 5.  The aging gastrointestinal tract.

Authors:  M C Geokas; B J Haverback
Journal:  Am J Surg       Date:  1969-06       Impact factor: 2.565

6.  Estimation of glomerular filtration rate by serum creatinine and serum beta 2-microglobulin.

Authors:  B Trollfors; R Norrby
Journal:  Nephron       Date:  1981       Impact factor: 2.847

7.  Brain cholinergic dysfunction and memory in aged rats.

Authors:  A S Lippa; R W Pelham; B Beer; D J Critchett; R L Dean; R T Bartus
Journal:  Neurobiol Aging       Date:  1980       Impact factor: 4.673

8.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.

Authors:  G Ciabattoni; G A Cinotti; A Pierucci; B M Simonetti; M Manzi; F Pugliese; P Barsotti; G Pecci; F Taggi; C Patrono
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

9.  Creatinine clearance in renal disease. A reappraisal.

Authors:  K E Kim; G Onesti; O Ramirez; A N Brest; C Swartz
Journal:  Br Med J       Date:  1969-10-04

10.  The place of the calcium antagonist verapamil in antihypertensive therapy.

Authors:  F R Bühler; U L Hulthén; W Kiowski; F B Müller; P Bolli
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

View more
  60 in total

1.  New antidepressants for old people?

Authors:  M G Livingston; H M Livingston
Journal:  BMJ       Date:  1999-06-19

2.  Facility-level variation in potentially inappropriate prescribing for older veterans.

Authors:  Walid F Gellad; Chester B Good; Megan E Amuan; Zachary A Marcum; Joseph T Hanlon; Mary Jo V Pugh
Journal:  J Am Geriatr Soc       Date:  2012-06-21       Impact factor: 5.562

Review 3.  Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 4.  Predicting and preventing adverse drug reactions in the very old.

Authors:  Louis Merle; Marie-Laure Laroche; Thierry Dantoine; Jean-Pierre Charmes
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 6.  To scale or not to scale: the principles of dose extrapolation.

Authors:  Vijay Sharma; John H McNeill
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

7.  Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology.

Authors:  Akshanth R Polepally; Rory P Remmel; Richard C Brundage; Ilo E Leppik; John O Rarick; R Eugene Ramsay; Angela K Birnbaum
Journal:  J Clin Pharmacol       Date:  2015-08-18       Impact factor: 3.126

8.  Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.

Authors:  Linda C Johansson; Lars Frison; Ulrika Logren; Gunnar Fager; David Gustafsson; Ulf G Eriksson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

Authors:  Emilio Perucca
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 10.  The doctor's duty to the elderly patient in clinical trials.

Authors:  Antony Bayer; Mark Fish
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.